SI-BONE, Inc. (SIBN)
NASDAQ
Closed
Oct 8, 2026
Day's Range
18.4252 wk Range
11.48Overview - SIBN - SI-BONE, Inc.
Key Statistics
Valuation
Enterprise Value
742.13M
P/E (Trailing)
‪-44.02‬
P/E (Forward)
‪-57.00‬
PEG Ratio
‪1.23‬
Price / Sales (TTM)
‪3.95‬
Price / Book
‪4.62‬
EV / EBITDA
‪-65.53‬
Profitability
Gross Margin
‪79.53%‬
Profit Margin
‪-6.85%‬
Operating Margin
‪-8.58%‬
Return on Assets
‪-4.62%‬
Return on Equity
‪-8.29%‬
Ownership
Shares Outstanding
44.69M
Float
39.98M
Short % of Shares Outstanding
‪15.38%‬
Held by Insiders
‪3.24%‬
Held by Institutions
‪109.60%‬
Price stats
Beta
‪0.66‬
50-Day Avg
‪18.79‬
200-Day Avg
‪16.33‬
Analyst Consensus
9 analysts
Average price target
‪$ 25.00‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - SIBN - SI-BONE, Inc.
Peers - SIBN - SI-BONE, Inc.
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
- SIBNNASDAQSI-BONE, Inc.868.13MMarket Cap+23.70%52-week change-44.02P/E (Trailing)‪-6.85%‬Profit Margin
- DXCMNASDAQDexCom Inc.32.21BMarket Cap+22.26%52-week change33.74P/E (Trailing)‪20.11%‬Profit Margin
- GEHCNASDAQGE HealthCare Technologies Inc.29.90BMarket Cap-9.28%52-week change15.09P/E (Trailing)‪9.33%‬Profit Margin
- TLTLTNASDAQiShares 20+ Year Treasury Bond ETF9.46BMarket Cap-14.44%52-week change—P/E (Trailing)—Profit Margin
- PODDNASDAQInsulet Corporation9.13BMarket Cap-136.69%52-week change24.66P/E (Trailing)‪12.29%‬Profit Margin
- BRKRNASDAQBruker Corp.8.96BMarket Cap+38.43%52-week change74.88P/E (Trailing)‪-2.03%‬Profit Margin
- LIVNNASDAQLivaNova PLC4.19BMarket Cap+32.22%52-week change22.60P/E (Trailing)‪12.81%‬Profit Margin
Profile Summary - SIBN - SI-BONE, Inc.
About
SI-BONE, Inc. is a medical device company focused on developing procedural solutions for musculoskeletal disorders of the sacropelvic anatomy. SI-BONE’s product portfolio centers on minimally invasive implant systems designed for sacroiliac joint fusion, pelvic fixation, and related orthopedic applications. Its…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
